Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Avenue Therapeutics' Return on Capital Employed [ROCE] came in at -355.46% for Q2 2026, down 105.90 percentage points from -249.56% a year earlier and down 223.04 percentage points from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Avenue Therapeutics' Return on Capital Employed [ROCE] was -181.09%, up 599.74 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -80.72 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -780.83% in FY2024 (-319.46 pp), -461.37% in FY2023 (-20.29 pp), -441.07% in FY2022 (-320.24 pp) and -120.83% in FY2021 (-20.47 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year-over-year, Return on Capital Employed [ROCE] increased in five of the last six quarters, with an average year-over-year change of +270.14 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2022 (a gain of 1311.66 percentage points), and the weakest in Q4 2022 (a drop of 5933.74 percentage points).
  • Business Quant data shows ATXI's Return on Capital Employed [ROCE] at -132.42% (Q1 2026), -138.36% (Q4 2025) and -155.81% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -355.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -355.46%
Mar 31, 2026 -132.42%
Dec 31, 2025 -138.36%
Sep 30, 2025 -155.81%
Jun 30, 2025 -249.56%
Mar 31, 2025 -506.68%
Dec 31, 2024 -615.72%
Sep 30, 2024 -416.66%
Jun 30, 2024 -358.70%
Mar 31, 2024 -1,011.82%
Dec 31, 2022 -6,139.69%
Sep 30, 2022 -2,866.48%
Jun 30, 2022 -489.43%
Mar 31, 2022 -259.14%
Dec 31, 2021 -205.95%
Sep 30, 2021 -4,178.14%
Jun 30, 2021 -391.56%
Mar 31, 2021 -232.42%
Dec 31, 2020 -178.99%
Sep 30, 2020 -260.19%
API Access

Avenue Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATXI&period=max&api_key=YOUR_API_KEY